SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report
Abstract
BackgroundSeizure-related 6 homolog-like 2 (SEZ6L2) antibody-associated cerebellar ataxia is a rare autoimmune disorder with very limited cases reported in the literature. Responses to conventional immunotherapy are variable.Case presentationWe present the case of a patient initially misdiagnosed with alcohol-related brain damage (ARBD) and type 2 diabetes-associated peripheral neuropathy. Following the detection of anti-SEZ6L2 antibodies in both serum and cerebrospinal fluid, the diagnosis was revised to SEZ6L2 antibody-associated cerebellar ataxia. The patient exhibited clinical improvement following combination therapy with double filtration plasmapheresis (DFPP) and glucocorticoids.ConclusionThis case highlights the diagnostic challenges of SEZ6L2 autoimmunity, which can mimic toxic or metabolic encephalopathies. Clinical improvement following combined DFPP and glucocorticoid treatment supports a potential therapeutic role for this approach but cannot prove antibody pathogenicity or the independent efficacy of DFPP.
Related
- Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma
- Oral glucocorticoids added to ILD‐modifying therapy in systemic sclerosis‐associated interstitial lung disease: a target trial emulation study from the EUSTAR database.
- A blistering neonatal nodule: Diagnostic challenges in cutaneous mastocytoma
- Netherton syndrome presenting with generalized erythroderma in a preterm neonate: Diagnostic and therapeutic challenges.
- Understanding diagnostic challenges and identifying priorities to tackle antimicrobial resistance in conflict zones
BibTeX
@article{zhu2026sez6l2,
title = {{SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report}},
author = {Chunping Zhu and Tiantian Jiang and Bin Liu and Yuhui Wang and Yuhong Ma},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1869743},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869743},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report
AU - Chunping Zhu
AU - Tiantian Jiang
AU - Bin Liu
AU - Yuhui Wang
AU - Yuhong Ma
PY - 2026
DA - 2026/11/16
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1869743
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1869743
AB - BackgroundSeizure-related 6 homolog-like 2 (SEZ6L2) antibody-associated cerebellar ataxia is a rare autoimmune disorder with very limited cases reported in the literature. Responses to conventional immunotherapy are variable.Case presentationWe present the case of a patient initially misdiagnosed with alcohol-related brain damage (ARBD) and type 2 diabetes-associated peripheral neuropathy. Following the detection of anti-SEZ6L2 antibodies in both serum and cerebrospinal fluid, the diagnosis was revised to SEZ6L2 antibody-associated cerebellar ataxia. The patient exhibited clinical improvement following combination therapy with double filtration plasmapheresis (DFPP) and glucocorticoids.ConclusionThis case highlights the diagnostic challenges of SEZ6L2 autoimmunity, which can mimic toxic or metabolic encephalopathies. Clinical improvement following combined DFPP and glucocorticoid treatment supports a potential therapeutic role for this approach but cannot prove antibody pathogenicity or the independent efficacy of DFPP.
SN - 1664-3224
ER -